|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/28/24 Acadia Healthcare Co., Inc. 10-K 12/31/23 128:15M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 3.43M
2: EX-21 Subsidiaries List HTML 338K
3: EX-22 Published Report re: Matters Submitted to a Vote HTML 48K
of Security Holders
4: EX-23 Consent of Expert or Counsel HTML 34K
9: EX-97 Clawback Policy re: Recovery of Erroneously HTML 53K
Awarded Compensation
5: EX-31.1 Certification -- §302 - SOA'02 HTML 39K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 39K
7: EX-32.1 Certification -- §906 - SOA'02 HTML 36K
8: EX-32.2 Certification -- §906 - SOA'02 HTML 36K
11: R1 Document and Entity Information HTML 107K
12: R2 Consolidated Balance Sheets HTML 136K
13: R3 Consolidated Balance Sheets (Parenthetical) HTML 50K
14: R4 Consolidated Statements of Operations HTML 162K
15: R5 Consolidated Statements of Operations HTML 35K
(Parenthetical)
16: R6 Consolidated Statements of Comprehensive (Loss) HTML 72K
Income
17: R7 Consolidated Statements of Comprehensive (Loss) HTML 35K
Income (Parenthetical)
18: R8 Consolidated Statements of Equity HTML 79K
19: R9 Consolidated Statements of Cash Flows HTML 173K
20: R10 Pay vs Performance Disclosure HTML 46K
21: R11 Insider Trading Arrangements HTML 41K
22: R12 Description of Business and Basis of Presentation HTML 42K
23: R13 Summary of Significant Accounting Policies HTML 74K
24: R14 Revenue HTML 122K
25: R15 Earnings Per Share HTML 97K
26: R16 Acquisitions HTML 52K
27: R17 Other current assets HTML 58K
28: R18 Property and Equipment HTML 58K
29: R19 Other Intangible Assets HTML 77K
30: R20 Leases HTML 192K
31: R21 The CARES Act HTML 47K
32: R22 Commitments and Contingencies HTML 52K
33: R23 Other accrued liabilities HTML 65K
34: R24 Long-Term Debt HTML 104K
35: R25 Noncontrolling Interests HTML 53K
36: R26 Variable Interest Entities HTML 83K
37: R27 Equity HTML 43K
38: R28 Equity-Based Compensation HTML 193K
39: R29 Transaction, Legal and Other Costs HTML 53K
40: R30 Income Taxes HTML 215K
41: R31 Fair Value Measurements HTML 59K
42: R32 Employee Benefit Plans HTML 40K
43: R33 U.K. Sale HTML 61K
44: R34 Accumulated Other Comprehensive Loss HTML 62K
45: R35 Derivatives HTML 37K
46: R36 Subsequent Events HTML 42K
47: R37 Summary of Significant Accounting Policies HTML 94K
(Policies)
48: R38 Revenue (Tables) HTML 105K
49: R39 Earnings Per Share (Tables) HTML 95K
50: R40 Acquisitions (Tables) HTML 49K
51: R41 Other current assets (Tables) HTML 58K
52: R42 Property and Equipment (Tables) HTML 55K
53: R43 Other Intangible Assets (Tables) HTML 75K
54: R44 Leases (Tables) HTML 193K
55: R45 Other accrued liabilities (Tables) HTML 64K
56: R46 Long-Term Debt (Tables) HTML 73K
57: R47 Noncontrolling Interests (Tables) HTML 49K
58: R48 Variable Interest Entities (Tables) HTML 81K
59: R49 Equity-Based Compensation (Tables) HTML 187K
60: R50 Transaction, Legal and Other Costs (Tables) HTML 53K
61: R51 Income Taxes (Tables) HTML 206K
62: R52 Fair Value Measurements (Tables) HTML 55K
63: R53 U.K. Sale (Tables) HTML 58K
64: R54 Accumulated Other Comprehensive Loss (Tables) HTML 61K
65: R55 Description of Business and Basis of Presentation HTML 41K
- Additional Information (Detail)
66: R56 Summary of Significant Accounting Policies - HTML 153K
Additional Information (Detail)
67: R57 Revenue - Additional Information (Detail) HTML 51K
68: R58 Revenue - Schedule of Revenue Attributed to Each HTML 54K
Category (Detail)
69: R59 Revenue - Schedule of Revenue and Percentage HTML 56K
Generated by Each Payor Type (Detail)
70: R60 Earnings Per Share - Computation of Basic and HTML 98K
Diluted Earnings Per Share (Detail)
71: R61 Earnings Per Share - Additional Information HTML 39K
(Detail)
72: R62 Acquisitions - Additional Information (Detail) HTML 54K
73: R63 Acquisitions - Summary of Changes in Goodwill HTML 44K
(Detail)
74: R64 Other Current Assets - Other Current Assets HTML 53K
(Details)
75: R65 Property and Equipment - Summary of Property and HTML 51K
Equipment (Detail)
76: R66 Property and Equipment - Additional information HTML 43K
(Detail)
77: R67 Other Intangible Assets - Other Identifiable HTML 53K
Intangible Assets and Related Accumulated
Amortization (Detail)
78: R68 Other Intangible Assets - Additional Information HTML 36K
(Detail)
79: R69 Leases - Additional Information (Detail) HTML 45K
80: R70 Leases - Schedule of Leases on Consolidated HTML 62K
Balance Sheet (Detail)
81: R71 Leases - Schedule of Weighted-average Remaining HTML 43K
Lease Terms and Discount Rates (Detail)
82: R72 Leases - Schedule of Lease Cost (Detail) HTML 53K
83: R73 Leases - Schedule of Undiscounted Future Cash HTML 82K
Flows for Finance and Operating Leases (Detail)
84: R74 Leases - Schedule of Supplemental Data (Detail) HTML 44K
85: R75 The CARES Act - Additional Information (Detail) HTML 74K
86: R76 Commitments and Contingencies (Additional HTML 49K
Information) (Details)
87: R77 Other accrued liabilities - Summary of Other HTML 61K
Accrued Liabilities (Details)
88: R78 Long-Term Debt - Components of Long-Term Debt HTML 66K
(Detail)
89: R79 Long-Term Debt - Components of Long-Term Debt HTML 49K
(Parenthetical) (Detail)
90: R80 Long-Term Debt (Credit Facility) - Additional HTML 126K
Information (Detail)
91: R81 Long-Term Debt (5.500% Senior Notes due 2028) - HTML 52K
Additional Information (Detail)
92: R82 Long-Term Debt (5.000% Senior Notes due 2029) - HTML 56K
Additional Information (Detail)
93: R83 Long-Term Debt (5.625% Senior Notes due 2023) - HTML 57K
Additional Information (Detail)
94: R84 Long-Term Debt (6.500% Senior Notes due 2024) - HTML 54K
Additional Information (Detail)
95: R85 Long-Term Debt (Redemption of 5.265% Senior Notes HTML 62K
and 6.500% Senior Notes) - Additional Information
(Detail)
96: R86 Long-Term Debt (Other Long-term Debt) - Additional HTML 35K
Information (Detail)
97: R87 Long-Term Debt (Debt Issuance Costs) - Additional HTML 39K
Information (Detail)
98: R88 Long-Term Debt (Other) - Summary of Aggregate HTML 50K
Maturities of Long-Term Debt (Detail)
99: R89 Noncontrolling Interests - Additional Information HTML 42K
(Detail)
100: R90 Noncontrolling Interests - Summary of Redeemable HTML 45K
Noncontrolling Interests (Detail)
101: R91 Variable Interest Entities - Additional HTML 63K
Information (Detail)
102: R92 Variable Interest Entities - Schedule of HTML 108K
Consolidated VIEs Assets and Liabilities (Detail)
103: R93 Equity - Additional Information (Detail) HTML 42K
104: R94 Equity-Based Compensation - Additional Information HTML 75K
(Detail)
105: R95 Equity-Based Compensation - Stock Option Activity HTML 69K
(Detail)
106: R96 Equity-Based Compensation - Schedule of Stock HTML 43K
Options Valuation Assumptions (Detail)
107: R97 Equity-Based Compensation - Restricted Stock Unit HTML 64K
Activity (Detail)
108: R98 Equity-Based Compensation - Performance Stock Unit HTML 69K
Activity (Detail)
109: R99 Transaction, Legal and Other Costs - Transaction, HTML 42K
Legal and Other Costs as Incurred (Details)
110: R100 Income Taxes - Components of (Benefit from) HTML 62K
Provision for Income Taxes From Continuing
operations (Detail)
111: R101 Income Taxes - Effective Income Tax Rate (Detail) HTML 58K
112: R102 Income Taxes - Additional Information (Detail) HTML 90K
113: R103 Income Taxes - Summary of Domestic and Foreign HTML 43K
Components of (Loss) Income from Continuing
Operations before Income Taxes (Detail)
114: R104 Income Taxes - Deferred Tax Assets and Liabilities HTML 82K
(Detail)
115: R105 Income Taxes - Unrecognized Income Tax Benefits HTML 40K
(Detail)
116: R106 Fair Value Measurements - Carrying Amounts and HTML 55K
Fair Values of Credit Facilities and Contingent
Consideration Liabilities (Detail)
117: R107 Fair Value Measurements - Additional Information HTML 47K
(Detail)
118: R108 Employee Benefit Plans - Additional Information HTML 38K
(Detail)
119: R109 U.K. Sale - Additional Information (Detail) HTML 56K
120: R110 U.K. Sale - Result of Operation (Detail) HTML 70K
121: R111 Accumulated Other Comprehensive Loss - Components HTML 59K
of Accumulated Other Comprehensive Loss (Detail)
122: R112 Accumulated Other Comprehensive Loss - Components HTML 36K
of Accumulated Other Comprehensive Loss
(Parenthetical) (Detail)
123: R113 Subsequent Events - Additional Information HTML 68K
(Details)
125: XML IDEA XML File -- Filing Summary XML 245K
128: XML XBRL Instance -- achc-20231231_htm XML 3.37M
124: EXCEL IDEA Workbook of Financial Report Info XLSX 225K
10: EX-101.SCH XBRL Taxonomy Extension Schema With Embedded XSD 5.34M
Linkbases Document -- achc-20231231
126: JSON XBRL Instance as JSON Data -- MetaLinks 760± 1.21M
127: ZIP XBRL Zipped Folder -- 0000950170-24-022057-xbrl Zip 575K
| EX-32.2 |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Acadia Healthcare Company, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Heather Dixon, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
Date: February 28, 2024 |
|
|
|
|
|
|
|
/s/ Heather Dixon |
|
|
|
|
|
Chief Financial Officer |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/28/24 | None on these Dates | ||
| For Period end: | 12/31/23 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/02/24 Acadia Healthcare Co., Inc. 10-Q 3/31/24 83:7.8M Donnelley … Solutions/FA |